Atrial septal defect (adult)
Shunt lesion in adults · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An atrial septal defect allows left-to-right shunting that may present in adulthood with exertional dyspnoea, palpitations or an incidental murmur. Significant shunts cause right-heart volume overload and warrant closure to prevent pulmonary hypertension and arrhythmia.
Red flags
- Cyanosis or reversed (right-to-left) shunt (Eisenmenger)
- Signs of severe pulmonary hypertension
- Paradoxical embolic stroke
- New atrial fibrillation/flutter
- Progressive RV dilatation and failure
Assessment
Differential diagnosis
- Patent foramen ovale
- Partial anomalous pulmonary venous return
- Ventricular septal defect
- Pulmonary hypertension of other cause
- Functional murmur
- Sinus venosus or primum defect
Investigations
- Transthoracic echo with bubble study (RV dilatation, shunt)
- Transoesophageal echo to define defect type/size and rims
- ECG (RBBB; right-axis deviation in secundum, left-axis in primum)
- Right-heart catheterisation if pulmonary hypertension suspected
- Cardiac MRI/CT for anomalous venous drainage
- Oxygen saturations to assess shunt direction
Management
- Confirm the defect, its type and shunt magnitude (Qp:Qs)
- Assess for right-heart volume overload and pulmonary artery pressure
- Identify sinus venosus/primum defects which usually need surgical repair
- Refer haemodynamically significant secundum defects (RV overload, Qp:Qs ≥1.5:1) for closure
- Prefer percutaneous device closure for suitable secundum defects with adequate rims
- Measure pulmonary vascular resistance before closing in suspected pulmonary hypertension
- Do not close if severe irreversible pulmonary hypertension/Eisenmenger physiology
- Manage associated atrial arrhythmias and anticoagulate as indicated
- Give antiplatelet therapy for a period after device closure
- Screen for and manage paradoxical embolism history
- Arrange endocarditis-awareness advice post device
- Follow up with echo to confirm closure and RV remodelling
Drugs & doses
Aspirin 75-100 mg PO OD after device closure (often 6 months)
Clopidogrel 75 mg PO OD added short-term after some device closures
Apixaban 5 mg PO BD if atrial fibrillation coexists
Pulmonary vasodilators (e.g. sildenafil, macitentan) only in specialist PAH management
Disposition
Refer to adult congenital heart disease (ACHD) service for assessment and closure. Lifelong specialist follow-up after intervention.
Complications & pitfalls
- Pulmonary arterial hypertension / Eisenmenger syndrome
- Atrial arrhythmias
- Paradoxical embolism and stroke
- Right heart failure
- Device-related complications (erosion, residual shunt)
Exam pearls
- Fixed splitting of the second heart sound is the classic examination sign
- Secundum defects are device-closable; sinus venosus and primum usually need surgery
- Closure late in life still benefits by reducing arrhythmia and RV overload
- Do not close a defect that has become the escape valve in severe pulmonary hypertension
- A bubble study greatly improves detection of interatrial shunting
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.